Sign In
Buy NTRA
$234.76
+5.96 (+2.60%)
At Close: Jun 23, 2026
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced the results of its DEFINE-HT clinical trial in heart transplantation, which
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
11:45am, Tuesday, 29'th Apr 2025
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test
07:00am, Thursday, 24'th Apr 2025
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its ultra-sensitive Signatera Genome assay is now broadly availa
Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting
04:05pm, Tuesday, 22'nd Apr 2025
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that data from 8 studies will be shared at the American Association o
27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks
07:00am, Monday, 07'th Apr 2025
Stanley Druckenmiller is in an elite league of investors that includes the likes of Warren Buffett. He ran his hedge fund firm, Duquesne Capital Management, for 30 years, posting eye-popping average a
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting
07:00am, Tuesday, 25'th Mar 2025
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
07:00am, Wednesday, 19'th Mar 2025
Stanley Druckenmiller, whose net worth is around $6.9 billion, made most of his fortune as a hedge fund manager, and became a well-known name on Wall Street while working for George Soros until 2000.
Natera: Growth Looks Unstoppable, Positive EPS Just A Matter Of Time
11:52am, Monday, 17'th Mar 2025
Natera: Growth Looks Unstoppable, Positive EPS Just A Matter Of Time
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
08:00am, Monday, 10'th Mar 2025
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced the enrollment of the first patients in the HEROES clinical trial. HE
Natera (NTRA) Reports Q4 Earnings: What Key Metrics Have to Say
10:30am, Friday, 07'th Mar 2025
While the top- and bottom-line numbers for Natera (NTRA) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare
Natera, Inc. (NTRA) Q4 2024 Earnings Call Transcript
12:23am, Friday, 28'th Feb 2025
Natera, Inc. (NASDAQ:NTRA ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Mike Brophy - Chief Financial Officer Steve Chapman - Chief Executive Officer Alexey Ales
Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates
07:25pm, Thursday, 27'th Feb 2025
Natera (NTRA) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $0.64 per share a year ago.
Natera Reports Fourth Quarter and Full Year 2024 Financial Results
04:05pm, Thursday, 27'th Feb 2025
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the fourth quarter and full year ended Decem
Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer
06:00am, Tuesday, 25'th Feb 2025
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its Signatera test has met coverage requirements from the Center
Natera (NTRA) Recently Broke Out Above the 20-Day Moving Average
10:35am, Monday, 17'th Feb 2025
From a technical perspective, Natera (NTRA) is looking like an interesting pick, as it just reached a key level of support. NTRA recently overtook the 20-day moving average, and this suggests a short-
